HopeStage
Back to all studies
RecruitingNCT06142955

Single-session brain stimulation for depression in autistic people

About this titleRead the official source — NCT06142955
Device studyAges 18–40United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 40 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 30, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Yale University
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 40 Years
Official registry ID
NCT06142955
Official title
Show the full official title

Neuromodulation for Depression in Autism Spectrum Disorder

Recruitment & locations

Currently recruiting

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who can participate?

Listed age limits: 18 years to 40 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies